Tocilizumab therapy reduced intensive care unit admissions and/or mortality in COVID-19 patients

INTRODUCTION: No therapy has yet proven effective in COVID-19. Tocilizumab (TCZ) in patients with severe COVID-19 could be an effective treatment. METHOD: We conducted a retrospective case-control study in the Nord Franche-Comté Hospital, France. We compared the outcome of patients treated with TCZ...

Full description

Saved in:
Bibliographic Details
Published in:Med Mal Infect
Main Authors: Klopfenstein, T., Zayet, S., Lohse, A., Balblanc, J.-C., Badie, J., Royer, P.-Y., Toko, L., Mezher, C., Kadiane-Oussou, N.J., Bossert, M., Bozgan, A.-M., Charpentier, A., Roux, M.-F., Contreras, R., Mazurier, I., Dussert, P., Gendrin, V., Conrozier, T.
Format: Artigo
Language:Inglês
Published: Elsevier Masson SAS. 2020
Subjects:
Original Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC7202806/
https://ncbi.nlm.nih.gov/pubmed/32387320
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.medmal.2020.05.001
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items